Clinical Trial Update: Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pantoprazole as a prophylaxis against delayed chemotherapy-induced nausea and vomiting in patients receiving breast cancer chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: University of Auckland, New Zealand | Conditions: Oncology, Breast Cancer | Phase 2 | Status: COMPLETED